46 results
8-K
EX-99.1
STRO
Sutro Biopharma Inc
21 Nov 23
Departure of Directors or Certain Officers
4:05pm
in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com.
Forward-Looking Statements
8-K
EX-99.1
STRO
Sutro Biopharma Inc
2 Apr 24
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
6:04am
on social media @Sutrobio, or visit www.sutrobio.com.
Ipsen contacts
Email: corporate.communications@ipsen.com
Investors
Craig Marks | + 44 7584
8-K
EX-99.1
STRO
Sutro Biopharma Inc
25 Mar 24
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com.
Forward-Looking Statements
This press release contains forward
8-K
EX-99.1
zbjlr5gqv
13 May 24
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
8-K
EX-99.1
k06zywud3puc
13 Nov 23
Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
PRE 14A
39jlq2j
14 Apr 23
Preliminary proxy
4:05pm
DRS
EX-10.3
60dztd96
1 Jun 18
Draft registration statement
12:00am
S-8
EX-99.1
y2w90q2q3 xq3j4eeo4
31 Aug 22
Registration of securities for employees
4:32pm
S-8
EX-99.1
h2puzlo1yq189w9fqxag
9 Aug 21
Registration of securities for employees
12:00am
S-3
EX-1.2
d3ydce
4 Oct 19
Shelf registration
4:06pm
S-3ASR
EX-1.2
xcym9d
2 Apr 21
Automatic shelf registration
4:59pm
8-K
EX-1.1
9xhpt295
9 Feb 24
Other Events
4:27pm
8-K
EX-1.1
2wmhb2rtz
9 Dec 20
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-1.1
zjkispo71
12 May 20
Entry into a Material Definitive Agreement
5:14pm